Search
Events

Association for Molecular Pathology

Roche Diagnostics at AMP 2023

Delivering Certainty

Enabling confident healthcare decisions to help drive operational, clinical and financial value

 

Roche provides innovative clinical diagnostic, life science research, dPCR and next-generation, sequencing-based solutions to empower your lab. We are dedicated to creating diagnostic tools and developing techniques that are tailored to individual genetic and disease profiles, meeting the demands of research and clinical practice to deliver on the promise of personalized healthcare.

Join us in booth no. 1000 at AMP 2023 in Salt Lake City, Utah, from November 14-18. Discover how our products and digital solutions can provide your healthcare institution with reliable results that clinicians need to help enhance patient care, especially in today's fast-changing and uncertain environment.

 

Join us on Wednesday, November 15, for our corporate workshops.

Expanding sensitivity and precision of oncology research assays with Roche Digital PCR and qPCR

8:00 - 8:50 a.m. local time

Our collaborator, GT Molecular, will explain how it took advantage of the Digital LightCycler® System’s six channels and higher sample volumes to develop sensitive and precise multiplexed oncology research assays. Data will highlight how the Digital LightCycler System enabled GT Molecular to clearly detect multiple targets without sacrificing sensitivity.

Learn about Roche’s new dual-mode (RUO & IVD) real-time PCR system, the LightCycler® PRO. This innovative, seven-channel instrument is designed to offer industry-leading multiplexing capabilities, plus the high precision, scalability, usability, and analytic capabilities found in Roche qPCR instruments.

Comparison of data from two commercially available tissue-based comprehensive genomic profiling solutions using AMP/ASCO/CAP guidelines and ESMO ESCAT

9:00 - 9:50 a.m. local time

We compared theoretical clinical significance data from two CGP solutions – the AVENIO Tumor Tissue CGP Kit for Research Use Only (RUO) paired with navify Mutation Profiler (nMP; RUO), and the TruSight Oncology 500 (TSO; RUO) assay paired with PierianDx Clinical Genomics Workspace. AVENIO and TSO assays were run on 145 FFPE solid tumor samples (prostate: n=28; breast: 27; colon: 26; lung: 25 [among others]).

Research Use Only. Not for use in diagnostic procedures.

From constraints to solutions: Unraveling the design challenges in molecular diagnostics

10:00 - 10:50 a.m. local time

Choosing the right components to mitigate the challenges in developing an assay can be intimidating. Key to balancing numerous, competing constraints, developers must carefully consider the raw materials used when developing an assay. 

Roche CustomBiotech has solutions to overcome these challenges. Join us for a discussion on our portfolio of reagents for use in development of centralized and point-of-care diagnostic assays.

Automating a lab developed protocol workflow using the cobas omni utility channel

11:00 - 11:50 a.m. local time

Lab-developed protocol plays a vital role in helping healthcare institutions defend against outbreaks and manage disease proliferation. Learn how industry peers have used the cobas omni Utility Channel to automate their solution to deliver innovative, effective and efficient testing solutions.

Sign up to schedule an in-person booth experience

Form Successfully Submitted!
Thank you for your submission!
text
close
cobas 5800
The next evolution of molecular testing with the cobas® 5800 system

Introducing the next-generation of molecular testing automation regardless of size, testing volume or mix. Improve productivity and reduce error, maximize the value of your lab space, scale efficiently as demands change, and ensure consistency across testing with standardized assays.

Learn more

cobas 5800
cobas® prime pre-analytical system

Offering complete standardization and automation of pre-analytics processing, the cobas prime system allows for continuous random loading for multiple sample types and tests to automate your molecular testing workflow.

Learn more

cobas 5800
Help clinicians improve patient care with multiplex molecular diagnostics on the ePlex® System

An automated approach to syndromic infectious disease testing for multiple disease states, including respiratory and bloodstream infections.

Learn more

cobas 5800
LightCycler® PRO System

Light the way from research to clinical diagnostics with Roche's new dual-mode (RUO & IVD) real-time PCR system. Built upon proven technology, the LightCycler PRO allows the ability to amplify confidence in your results, adapt quickly to your evolving testing needs, and simplify your workflow with convenient data management options.

In development. Not available in the U.S.

cobas 5800
Digital LightCycler® dPCR System

A digital PCR system for DNA and RNA with a 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivity, precision, flexibility, and integration, the Digital LightCycler System is a powerful digital PCR system that aims to help laboratories push the boundaries of clinical research forward. Three configurations of consumables are available to meet varied application needs, including high sample volume for cfDNA screening or greater number of partitions for high-resolution CNV analysis.

Learn more

The Digital LightCycler® is a Class II US IVD instrument

cobas 5800
AVENIO Tumor Tissue CGP Kit

Bring the power of Foundation Medicine® and Roche into your lab. The AVENIO Tumor Tissue CGP Kit is an in-house next-generation sequencing (NGS) research assay that provides comprehensive genomic profiling of solid tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples. Designed to match the content of the 324-gene FoundationOne® CDx panel, the kit leverages the proven technology of Foundation Medicine to help your lab obtain reliable genomic insights.

Learn more

AVENIO Tumor Tissue CGP Kit is for Research Use Only. Not for use in diagnostic procedures.

FOUNDATIONONE is a trademark of Foundation Medicine, Inc.

cobas 5800

 

AVENIO Edge Liquid Handler for NGS Library Prep

Simplify NGS library prep with the AVENIO Edge System, a fully automated platform for end-to-end library prep, target enrichment, quantification, pooling and normalization. Designed for easy setup — even for users with no NGS or automation experience - with ready-to-load barcoded reagent cartridges and intuitive software.

Learn more

AVENIO Edge System is a Class 1 U.S. IVD instrument and is intended for downstream diagnostic applications.

AVENIO Edge reagents and workflows are for Research Use Only. They are not intended for diagnostic applications.

navify
navify Mutation Profiler

Simplify NGS Tertiary Analysis

navify Mutation Profiler is a Next-Generation Sequencing (NGS) reporting solution that can help labs and researchers confidently, clearly and efficiently interpret the significance of mutations. navify Mutation Profiler increases lab efficiency and enables scalability by helping reduce curation time and by automating report generation. 

Learn more

navify Mutation Profiler is for Research Use Only. Not for use in diagnostic procedures.

 

Health topics

Latest news